COMP <GO>
NICE vs PATH // RETURN ON INVESTED CAPITAL (ROIC)
NICE Ltd (NASDAQ) VS. UiPath Inc. (NYSE) • 15-METRIC TALLY: NICE 8
— PATH 4
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: NICE
LAST: $112.39 (-1.20%) • MKT CAP: $6.68B
roic
11.30%
LAST: $13.34 (-2.84%) • MKT CAP: $6.95B
roic
2.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NICE VS. PATH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NICE | PATH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.40% | 83.20% | -16.80 | PATH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 11.30% | 2.70% | +8.60 | NICE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.3x | 92.8x | -81.50 | NICE | /valuation <GO> |
| Free Cash Flow Yield | 10.21% | 4.90% | +5.31 | NICE | /fcf-yield <GO> |
| Operating Margin | 21.90% | 3.50% | +18.40 | NICE | /operating-margins <GO> |
| Net Profit Margin | 20.80% | 17.50% | +3.30 | NICE | /net-margins <GO> |
| Revenue Growth (YoY) | 7.70% | 12.70% | -5.00 | PATH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.69 | 4.25 | -0.56 | PATH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 9/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.8 | 44.5 | +1.30 | NICE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.27 | 1.21 | +0.06 | NICE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.4x | 21.3x | -10.90 | NICE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.68B | $6.95B | -$275.8M | PATH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NICE REV | PATH REV | NICE GROSS % | PATH GROSS % | NICE FCF | PATH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.95B | $1.61B | 66.4% | 83.2% | $697.6M | $352.2M |
| FY 2024 | $2.74B | $1.43B | 66.7% | 82.7% | $797.7M | $305.6M |
| FY 2023 | $2.38B | $1.31B | — | — | $454.4M | $240.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NICE // BETA 1.27
PATH // BETA 1.21